Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Blocking certain proteins on immune cells may help treat alopecia areata.

Inflammation damages sweat ducts, causing sweat gland injury.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

New scientific advancements offer hope for better treatments for skin fibrosis.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.